Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Earnings Seasons Score Card: 4 Stock Superstars and 3 That Fell Short
11:57am, Wednesday, 28'th Feb 2024
Earnings season for the fourth quarter of calendar 2023 is coming to a close. Clear winners and losers are emerging from the reports.
Moderna to Present at Upcoming Investor Conferences in March 2024
07:00am, Wednesday, 28'th Feb 2024
CAMBRIDGE, MA / ACCESSWIRE / February 28, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 44th Annual Healthcare Conferen
Moderna Stock Has 33% Upside, According to 1 Wall Street Analyst
06:38am, Wednesday, 28'th Feb 2024
Moderna is trying to move on from its coronavirus vaccine heyday. Its respiratory syncytial virus (RSV) vaccine could launch this year.
Cramer's Stop Trading: Moderna
10:58am, Monday, 26'th Feb 2024
CNBC's Jim Cramer explains why he is keeping an eye on shares of Moderna.
This pharma stock surged 13% in a day
04:14am, Friday, 23'rd Feb 2024
Moderna (NASDAQ: MRNA) stock significantly surged on February 22 after the company surpassed Wall Street's quarterly expectations.
Moderna (MRNA) CFO on Earnings & Covid Vaccine Sales
05:49pm, Thursday, 22'nd Feb 2024
Moderna (MRNA) expects regulatory approval for its investigational RSV vaccine for older adults starting in 1H24. Moderna CFO Jamey Mock discusses 4Q earnings, as well as Covid vaccine sales.
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
02:11pm, Thursday, 22'nd Feb 2024
Moderna (MRNA) beats expectations for earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.
Why Moderna Stock Is Jumping Today
11:24am, Thursday, 22'nd Feb 2024
Moderna beat Wall Street's revenue and earnings estimates in Q4. The company was helped by deferred revenue from Gavi, the Vaccine Alliance, and an income tax benefit.
Moderna (MRNA) Q4 Earnings and Revenues Beat Estimates
08:41am, Thursday, 22'nd Feb 2024
Moderna (MRNA) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of a loss of $0.78 per share. This compares to earnings of $3.61 per share a year ago.
Moderna Stock Jumps on Surprise Profit, Sales Ahead of Expectations
06:44am, Thursday, 22'nd Feb 2024
Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts' expectations.
Moderna posts surprise quarterly profit even as Covid vaccines sales plummet
06:34am, Thursday, 22'nd Feb 2024
Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.
Moderna reports surprise profit, sets out road map for RSV vaccine
06:31am, Thursday, 22'nd Feb 2024
Moderna on Thursday reported a surprise fourth-quarter profit helped by cost cutting and some deferred payments, and the vaccine maker set out a commercial roadmap for its experimental respiratory syn
Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More
10:16am, Wednesday, 21'st Feb 2024
Let us take a look at what's in store for biotech/drug stocks MRNA, BHC, NTLA, BMRN and ITCI, which are scheduled to report on Feb 22.
Why Earnings Season Could Be Great for Moderna (MRNA)
10:01am, Wednesday, 21'st Feb 2024
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Looming Layoffs? 3 Companies That May Be the Next to Drop the Axe.
04:33pm, Monday, 19'th Feb 2024
Al Jazeera has called 2023 “the year of the layoffs.” As the news organization pointed out recently, it started badly in 2023, when Salesforce (NYSE: CRM ) cut 10% of its global staff.
